Patients were randomised within 24 hours of onset of acute ischaemic stroke or high-risk transient ischaemic attack symptoms and followed-up for 30 days of treatment.
News
Spravato rejected by NICE
The committee cited multiple uncertainties.
NICE rejections continue, hitting Novo’s Saxenda next
Obesity is very common in England, affecting about 26% of the adult population.
NIHR to invest £59m in AMR, air pollution and infectious diseases
The money will go towards 14 new NIHR Health Protection Research Units (HPRUs).
EU expands Stelara indication following NICE rejection
Just last week NICE released a draft guidance not recommending the medicine for moderately to severely active ulcerative colitis in adults.
Havas Lynx bags seven Golds at PM Society Awards
Reckitt Benckiser, VCCP and Teva were also successful on the night.
75% drop in cases from UK meningitis B vaccine
Starting in September 2015, UK infants were offered the meningitis B vaccine at two and four months old.
CMA pins down Tiofarma for illegal market sharing
Aspen, Amilco and Tiofarma are accused of taking part in an agreement that resulted in a price hike of fludrocortisone.
Video games encouraging ‘under the radar’ gambling
As it stands, 55,000 children are classed as having a gambling problem in the UK.
Tagrisso hit with NICE rejection for NSCLC
Unfortunately, the drug is not considered eligible for inclusion in the Cancer Drugs Fund either.
Opportunity awaits in the 2020 Clinical Researcher of the Year – The Americas competition
This annual competition has built up a strong reputation for uncovering the next set of talented clinical researchers currently working in North & South America.
Could beta-blockers slow the spread of cancer?
New research has suggested that the anti-stress drugs could stop cancer cells spreading through the body in women with breast cancer.
Robotic heart, heart attack vaccine among BHF Big Beat finalists
The remaining four teams will receive a small amount of seed funding – around £50,000 each – to help them win the £30 million funding award.
Cervical screening numbers hit ‘new low’
The “worrying trend” shows that less than three-quarters of women invited for cervical screening take it up.
QiC Dermatology now open for entries
QiC Programmes are run by PMGroup and were first launched in 2011 to bring the NHS, industry and patient groups closer together.
